• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSANZ 成像委员会关于 COVID-19 大流行期间超声心动图服务的立场声明。

CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic.

机构信息

University of Queensland, Brisbane, Qld, Australia.

Westmead Hospital, Sydney and Westmead Clinical School, University of Sydney, NSW, Australia.

出版信息

Heart Lung Circ. 2020 Jun;29(6):e78-e83. doi: 10.1016/j.hlc.2020.04.003. Epub 2020 May 6.

DOI:10.1016/j.hlc.2020.04.003
PMID:32467031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7202319/
Abstract

This Cardiac Society of Australia and New Zealand (CSANZ) Imaging Council Position Statement aims to guide local, regional and national clinical practice, and facilitate resource and echocardiographic service planning appropriately during the current COVID-19 global pandemic. General considerations include workforce arrangements and contingency plans, patient risk assessment for COVID-19 and level of care (personal protective equipment) for staff. Both outpatient and inpatient settings are addressed, including specific considerations in the in-patient setting including scanning protocols, screening modalities and indications for echocardiograms in the context of COVID-19 infection.

摘要

本澳大利亚和新西兰心脏协会(CSANZ)影像委员会立场声明旨在指导当前 COVID-19 全球大流行期间的当地、区域和国家临床实践,并为资源和超声心动图服务规划提供便利。一般考虑因素包括劳动力安排和应急计划、COVID-19 患者风险评估以及员工的护理水平(个人防护设备)。本声明涵盖了门诊和住院环境,包括住院环境中的具体考虑因素,包括在 COVID-19 感染背景下的扫描方案、筛查方式和超声心动图适应症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/ba33d5d3e9cb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/062adbb5fed9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/f128eba41876/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/ba33d5d3e9cb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/062adbb5fed9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/f128eba41876/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e59/7202319/ba33d5d3e9cb/gr3_lrg.jpg

相似文献

1
CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic.CSANZ 成像委员会关于 COVID-19 大流行期间超声心动图服务的立场声明。
Heart Lung Circ. 2020 Jun;29(6):e78-e83. doi: 10.1016/j.hlc.2020.04.003. Epub 2020 May 6.
2
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic.CSANZ 关于在 COVID-19 大流行期间评估疑似急性冠状动脉综合征患者的立场声明。
Heart Lung Circ. 2020 Jul;29(7):e105-e110. doi: 10.1016/j.hlc.2020.05.003. Epub 2020 May 21.
3
COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).COVID-19 和急性心力衰竭:危重症患者的筛查——澳大利亚和新西兰心脏协会(CSANZ)立场声明。
Heart Lung Circ. 2020 Jul;29(7):e94-e98. doi: 10.1016/j.hlc.2020.04.005. Epub 2020 May 1.
4
Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.遗传性心脏病患者与 COVID-19:澳大利亚和新西兰心脏协会(CSANZ)共识声明。
Heart Lung Circ. 2020 Jul;29(7):e85-e87. doi: 10.1016/j.hlc.2020.04.006. Epub 2020 Apr 30.
5
Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ).《澳大利亚和新西兰心脏病学会(CSANZ)在 COVID-19 大流行期间优化动脉粥样硬化性心血管疾病二级预防和心脏康复的立场声明》。
Heart Lung Circ. 2020 Jul;29(7):e99-e104. doi: 10.1016/j.hlc.2020.04.007. Epub 2020 Apr 30.
6
Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.农村和偏远地区心脏病学在 COVID-19 大流行期间:澳大利亚和新西兰心脏病学会(CSANZ)共识声明。
Heart Lung Circ. 2020 Jul;29(7):e88-e93. doi: 10.1016/j.hlc.2020.05.001. Epub 2020 May 7.
7
Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia During the COVID-19 Pandemic: A Living Document.COVID-19 大流行期间澳大利亚心脏电生理学和心脏植入式电子设备管理立场声明:一份实时文件。
Heart Lung Circ. 2020 Jun;29(6):e57-e68. doi: 10.1016/j.hlc.2020.04.001. Epub 2020 May 11.
8
Letter to the Editor: CSANZ Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand.致编辑的信:澳大利亚和新西兰新冠疫情期间介入心脏病学服务提供的CSANZ共识指南
Heart Lung Circ. 2020 Aug;29(8):1260-1261. doi: 10.1016/j.hlc.2020.05.091. Epub 2020 Jul 6.
9
CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council.CSANZ 关于 COVID-19 的立场声明来自儿科和先天性委员会。
Heart Lung Circ. 2020 Sep;29(9):e217-e221. doi: 10.1016/j.hlc.2020.07.005. Epub 2020 Jul 29.
10
Impact of the COVID-19 pandemic on surgical services: early experiences at a nominated COVID-19 centre.新型冠状病毒肺炎大流行对外科服务的影响:指定新型冠状病毒肺炎中心的早期经验
ANZ J Surg. 2020 May;90(5):663-665. doi: 10.1111/ans.15900. Epub 2020 Apr 15.

引用本文的文献

1
The Point-of-Care Ultrasound (POCUS) by the Handheld Ultrasound Devices (HUDs) in the COVID-19 Scenario: a Review of the Literature.新型冠状病毒肺炎疫情下手持式超声设备进行床旁超声检查的文献综述
SN Compr Clin Med. 2023;5(1):1. doi: 10.1007/s42399-022-01316-9. Epub 2022 Nov 15.
2
Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice.心肌炎与 COVID-19 及 mRNA 疫苗接种相关的心脏并发症:指导临床实践的实用叙事性综述。
Heart Lung Circ. 2022 Jul;31(7):924-933. doi: 10.1016/j.hlc.2022.03.003. Epub 2022 Apr 6.
3
Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID).

本文引用的文献

1
ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology.美国超声心动图学会关于在 2019 年新型冠状病毒爆发期间保护患者和超声心动图服务提供者的声明:得到美国心脏病学会的认可。
J Am Coll Cardiol. 2020 Jun 23;75(24):3078-3084. doi: 10.1016/j.jacc.2020.04.002. Epub 2020 Apr 6.
COVID-19 对大洋洲诊断性心脏程序量的影响:IAEA 非侵入性心脏病学协议对 COVID-19 的调查(INCAPS COVID)。
Heart Lung Circ. 2021 Oct;30(10):1477-1486. doi: 10.1016/j.hlc.2021.04.021. Epub 2021 May 16.
4
COVID-19 and Heart, Lung and Circulation: Riding the 2020 Waves of Change in Australia & New Zealand.新型冠状病毒肺炎与心脏、肺和循环系统:应对2020年澳大利亚和新西兰的变化浪潮
Heart Lung Circ. 2020 Dec;29(12):1737-1740. doi: 10.1016/j.hlc.2020.10.008.
5
Prime time for handheld echocardiography in COVID-19 pandemic.COVID-19大流行期间手持超声心动图的黄金时期。
Clin Med (Lond). 2020 Jul;20(4):e132. doi: 10.7861/clinmed.Let.20.4.3.
6
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.新型冠状病毒感染与心血管疾病:COVID-19 心脏。
Heart Lung Circ. 2020 Jul;29(7):973-987. doi: 10.1016/j.hlc.2020.05.101. Epub 2020 Jun 5.
7
Airway Management in the Operating Room and Interventional Suites in Known or Suspected COVID-19 Adult Patients: A Practical Review.已知或疑似 COVID-19 成年患者在手术室和介入套房中的气道管理:实用综述。
Anesth Analg. 2020 Sep;131(3):677-689. doi: 10.1213/ANE.0000000000005043.
8
Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.农村和偏远地区心脏病学在 COVID-19 大流行期间:澳大利亚和新西兰心脏病学会(CSANZ)共识声明。
Heart Lung Circ. 2020 Jul;29(7):e88-e93. doi: 10.1016/j.hlc.2020.05.001. Epub 2020 May 7.
9
COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).COVID-19 和急性心力衰竭:危重症患者的筛查——澳大利亚和新西兰心脏协会(CSANZ)立场声明。
Heart Lung Circ. 2020 Jul;29(7):e94-e98. doi: 10.1016/j.hlc.2020.04.005. Epub 2020 May 1.
10
Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic.与新冠疫情相关的心血管和后勤问题。
Heart Lung Circ. 2020 May;29(5):655-656. doi: 10.1016/j.hlc.2020.03.014. Epub 2020 Apr 10.